IP Verse

Methods Of Administering Fluvoxamine Therapy

PatentPatent Analysis

EP2653162

INTERMUNE
Application Number
EP13176914A
Filing Date
Dec 3, 2010
Status
Revoked
Jun 16, 2023
Grant Date
May 20, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3053580B1
EP2506850B1

Bibliography

The patent EP2653162B1 was granted to Intermune on May 20, 2020 following the initial filing on Dec 3, 2010 under the application number EP13176914A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHERFeb 19, 2021WITHDRAWN
INTAS PHARMACEUTICALSFeb 19, 2021WITHDRAWN
AERAFeb 16, 2021WITHDRAWN
SANDOZFeb 10, 2021WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents